Shanghai Hile Bio-Technology Co., Ltd. (SHA:603718)
2.900
-0.030 (-1.02%)
Aug 4, 2026, 3:00 PM CST
SHA:603718 Market Cap
SHA:603718 has a market cap or net worth of 1.89 billion as of August 4, 2026. Its market cap has decreased by -62.31% in one year.
Market Cap
1.89B
Enterprise Value
1.64B
Revenue
173.47M
Ranking
n/a
PE Ratio
n/a
Stock Price
2.90
ChartMarket Cap Chart
Since May 15, 2015, SHA:603718's market cap has decreased from 2.75B to 1.89B, a decrease of -31.17%. That is a compound annual growth rate of -3.27%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 4, 2026 | 1.89B | -52.73% |
| Dec 31, 2025 | 4.00B | -12.02% |
| Dec 31, 2024 | 4.55B | -35.48% |
| Dec 29, 2023 | 7.05B | 11.42% |
| Dec 30, 2022 | 6.32B | -35.82% |
| Dec 31, 2021 | 9.85B | 21.33% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Yantai Zhenghai Biotechnology | 2.54B |
| Novoprotein Scientific | 2.47B |
| Shandong Sito Bio-technology | 2.32B |
| Shanghai Universal Biotech | 2.20B |
| Suzhou Fushilai Pharmaceutical | 2.17B |
| Jilin Jian Yisheng Pharmaceutical | 2.14B |
| Jiangsu CoWin Biotech | 1.85B |
| Guiyang Xintian Pharmaceutical | 1.84B |